Literature DB >> 33313957

[Safe pregnancy after breast cancer treatment in patients carrying BRCA mutations?]

Rainer Souchon1.   

Abstract

Entities:  

Year:  2020        PMID： 33313957     DOI： 10.1007/s00066-020-01726-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

1.  Challenges of guarantee-time bias.

Authors:  Anita Giobbie-Hurder; Richard D Gelber; Meredith M Regan
Journal:  J Clin Oncol       Date:  2013-07-08       Impact factor: 44.544

2.  Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.

Authors:  Matteo Lambertini; Niels Kroman; Lieveke Ameye; Octavi Cordoba; Alvaro Pinto; Giovanni Benedetti; Maj-Britt Jensen; Shari Gelber; Maria Del Grande; Michail Ignatiadis; Evandro de Azambuja; Marianne Paesmans; Fedro A Peccatori; Hatem A Azim
Journal:  J Natl Cancer Inst       Date:  2018-04-01       Impact factor: 13.506

3.  Pregnancy after adolescent and adult cancer: a population-based matched cohort study.

Authors:  Hanne Stensheim; Milada Cvancarova; Bjørn Møller; Sophie D Fosså
Journal:  Int J Cancer       Date:  2011-04-27       Impact factor: 7.396

4.  The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation.

Authors:  Adriana Valentini; Jan Lubinski; Tomasz Byrski; Parviz Ghadirian; Pal Moller; Henry T Lynch; Peter Ainsworth; Susan L Neuhausen; Jeffrey Weitzel; Christian F Singer; Olufunmilayo I Olopade; Howard Saal; Dominique Stoppa Lyonnet; William D Foulkes; Charmaine Kim-Sing; Siranoush Manoukian; Dana Zakalik; Susan Armel; Leigha Senter; Charis Eng; Eva Grunfeld; Anna M Chiarelli; Aletta Poll; Ping Sun; Steven A Narod
Journal:  Breast Cancer Res Treat       Date:  2013-10-18       Impact factor: 4.872

5.  Association of the Timing of Pregnancy With Survival in Women With Breast Cancer.

Authors:  Javaid Iqbal; Eitan Amir; Paula A Rochon; Vasily Giannakeas; Ping Sun; Steven A Narod
Journal:  JAMA Oncol       Date:  2017-05-01       Impact factor: 31.777
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.